Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Optilume™ BPH Catheter System in Men With Symptomatic BPH

NCT: NCT04131907 · ACTIVE_NOT_RECRUITING

NCT IDNCT04131907
StatusACTIVE_NOT_RECRUITING
Start Date2020-02-05
Completion2027-05
SponsorUrotronic Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

PINNACLE is a prospective, multi-center, randomized control clinical trial to establish the safety and efficacy of the Optilume™ BPH Catheter System in the treatment of benign prostatic hyperplasia (BPH)

Frequently Asked Questions

What is Optilume™ BPH Catheter System in Men With Symptomatic BPH?

Optilume™ BPH Catheter System in Men With Symptomatic BPH is a clinical trial registered under NCT04131907. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04131907?

The current status of NCT04131907 (Optilume™ BPH Catheter System in Men With Symptomatic BPH) is: ACTIVE_NOT_RECRUITING.

When did Optilume™ BPH Catheter System in Men With Symptomatic BPH start?

Optilume™ BPH Catheter System in Men With Symptomatic BPH started on 2020-02-05.

Related Devices

PMA P220029Drug coated prostatic dilation catheter for benign prostatic hyperplasiaUrotronic, Inc. K191061Optilume Basic Urological Balloon Dilation CatheterUrotronic, Inc. K250910Optilume® High Pressure Urological Balloon Dilation CatheterUrotronic, Inc. PMA P210020Catheter, Balloon, Urethral, Drug-CoatedUrotronic, Inc. PMA P010055System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapyProstalund AB

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑